Chronic Immunosuppression and Potential Infection Risks in CSF1R-Related Leukoencephalopathy

Affiliations

¹ Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Solna, Sweden.
² Neuroepidemiology with focus on MS, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
³ Medical Unit Neurology, Karolinska University Hospital, Stockholm, Sweden.

Comment

Jinming Han et al. Mov Disord. 2021 Jun.

. 2021 Jun;36(6):1470-1471.

doi: 10.1002/mds.28627.

¹ Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Solna, Sweden.
² Neuroepidemiology with focus on MS, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
³ Medical Unit Neurology, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

Keywords: CSF1R gene; adult-onset leukoencephalopathy with spheroids and pigmented glia; glucocorticoids; immunosuppression; infection.

Comment in

Reply to: "Investigation of Disease Modifying Mechanisms in CSF1R-Related Leukoencephalopathy".
Tipton PW, Stanley ER, Chitu V, Wszolek ZK. Tipton PW, et al. Mov Disord. 2021 Jun;36(6):1471. doi: 10.1002/mds.28626. Mov Disord. 2021. PMID: 34145637 No abstract available.

Is Pre-Symptomatic Immunosuppression Protective in CSF1R-Related Leukoencephalopathy?
Tipton PW, Stanley ER, Chitu V, Wszolek ZK. Tipton PW, et al. Mov Disord. 2021 Apr;36(4):852-856. doi: 10.1002/mds.28515. Epub 2021 Feb 15. Mov Disord. 2021. PMID: 33590562 Free PMC article. No abstract available.